卡瑞利珠单抗 (INN:camrelizumab[1],研发代号SHR-1210,商品名艾瑞卡)是一种抗PD-1免疫检查点抑制剂,正在针对肝细胞癌的适应症进行多国临床试验。 [2]
该药物由江苏恒瑞医药有限公司开发,2019年起该药在多国接受Ⅱ/Ⅲ期临床试验。2019年底该药在中国上市。
参考文献
Wikiwand in your browser!
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.